Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204016 | SCV000262098 | likely benign | Hypertrophic cardiomyopathy | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001185553 | SCV001351802 | likely benign | Cardiomyopathy | 2019-04-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001568626 | SCV001792532 | likely benign | not provided | 2020-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381712 | SCV002671001 | likely benign | Cardiovascular phenotype | 2019-06-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV001185553 | SCV004239331 | likely benign | Cardiomyopathy | 2022-09-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000204016 | SCV004834687 | likely benign | Hypertrophic cardiomyopathy | 2023-12-13 | criteria provided, single submitter | clinical testing |